Filters: Author is Mostaghel, Elahe A [Clear All Filters]
In Reply to Bhattacharyya et al.. International journal of radiation oncology, biology, physics. 93(3):719-20.. 2015.
External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.. International journal of radiation oncology, biology, physics. 92(2):236-43.. 2015.
Androgen action and metabolism in prostate cancer.. Molecular and cellular endocrinology.. 2012.
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.. Nature clinical practice. Urology. 6(2):76-85.. 2009.
Characterization of an abiraterone ultraresponsive phenotype in castration-resistant prostate cancer patient-derived xenografts.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2016.
Prostate tissue androgens: history and current clinical relevance.. Urology. 72(2):247-54.. 2008.
Genomic strategy for targeting therapy in castration-resistant prostate cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(12):2022-9.. 2009.
Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.. Hormones & cancer. 2(3):145-56.. 2011.
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54.. 2008.
Glucocorticoids and prostate cancer treatment: friend or foe? Asian journal of andrology.. 2014.
Neoadjuvant Enzalutamide Prior to Prostatectomy.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2016.
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25.. 2011.
Practical guide to the use of abiraterone in castration resistant prostate cancer.. The Canadian journal of urology. 21(2 Supp 1):57-63.. 2014.
Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.. Best practice & research. Clinical endocrinology & metabolism. 22(2):243-58.. 2008.
Abiraterone in the treatment of metastatic castration-resistant prostate cancer.. Cancer management and research. 6:39-51.. 2014.
SLCO Transport Genes in Prostate Cancer--Response.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(10):2326-7.. 2011.
Beyond T and DHT - Novel Steroid Derivatives Capable of Wild Type Androgen Receptor Activation.. International journal of biological sciences. 10(6):602-613.. 2014.
Androgen Receptor Expression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications.. Experimental hematology.. 2017.
Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37.. 2014.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)